Back to Sepsis Alliance Institute Speakers

Kenneth E. Remy, MD, MHSc, MSCI, FCCM

Kenneth E. Remy, MD, MHSc, MSCI, FCCM

Associate Professor of Medicine, Pediatrics, Biochemistry, and Pathology

Host Immune Response-Remy Laboratory

Kenneth E. Remy, MD, MHSc, MSCI, FCCM, is a clinical associate professor at Case Western Research University in the departments of internal medicine, pediatrics, pathology, and biochemistry in the divisions of pulmonary critical care medicine and pediatric critical care medicine. He serves as the Director of the division of pulmonary critical care medicine basic science and translational critical care research and a Co-Director for clinical, basic science, and translational critical care research in the division of pediatric critical care medicine. He is also a fellow in the American College of Critical Care Medicine and fellow in the Society of Pediatric Research.

Dr. Remy is an international expert in adult and pediatric sepsis, COVID disease, and global health. He sits on a number of national and international task forces in sepsis and COVID including the NIH, BARDA, FDA and CDC. His research interests are in host inflammation in both adults and children with sepsis and how red blood cell transfusions further cause immune modulation in patients with inflammatory states. Dr. Remy has authored over 75 peer reviewed manuscripts, textbook chapters, and invited commentaries. He is the chair of the basic and translational science research section for the society of critical care medicine (SCCM) and the immunology chair for the pediatric acute lung injury and sepsis investigators blood network. 

Dr. Remy has been featured on a number of news programs including CNN, CBS Evening News, BBC News, People Magazine, NBC News, Reuters, USA today, and many other local and international news stations on his experiences during this pandemic. He regularly speaks on the immunologic consequences of disease, pediatric multisystem inflammatory syndrome (MIS-C), public health measures and schools, and potential therapies for SARS-CoV-2 infection. 

Courses By This Speaker

Sort By
Search by Keyword